Writing the Future of Biologics using the Twist Biopharma Library of Libraries

Presented by

Aaron Sato, PhD

Twist Bioscience

RECORDED AT AET Digital Week 2021

Covered in this Webinar

Hear how the latest libraries are opening new sequence space

Review work against human ACE2 & SARS-CoV-2 spike protein to find potently neutralizing candidate antibodies

Compare options for accessing the Library of Libraries, including licensing to fully outsource lead discovery

Utilizing its proprietary DNA technology to write synthetic libraries, Twist Biopharma provides end-to-end antibody discovery libraries including both (1) highly diverse synthetic naïve antibody phage display libraries and (2) target class specific antibody phage display libraries against difficult-to-drug targets. In this talk, Aaron Sato, CSO, will present several POC data on each member of their Library of Libraries. For some of the targets, the power of selecting multiple libraries against each target will be highlighted.

Share your details to Watch the Webinar

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

Writing the Future of Biologics using the Twist Biopharma Library of Libraries

Related Resources

Developing Therapeutics Against Virtually Any Target with New Antibody Libraries (Mandarin)

Precision Synthesis of Variant Libraries Enables Comprehensive Interrogation of Single-Site